Question explored with the scientific record
What funding and competing interests did Watson et al declare in their 2022 Lancet Infectious Diseases study on COVID-19 vaccination impact?
The retrieval did not surface the Watson et al. paper, so I cannot tell you what its authors declared.
No record in this retrieval is the 2022 Lancet Infectious Diseases study by Watson et al. on COVID-19 vaccination impact. The records that mention that journal are about other topics entirely: hepatitis B in China [2], tuberculosis tests [3], Crohn's disease [4], and a 2004 favorites list [1]. None of them is the paper you asked about, and none reports its funding or competing-interest statement.
I will not invent a funding source or a conflict-of-interest declaration. That is exactly the kind of detail that gets fabricated when someone answers from memory instead of the document. The honest answer is that this search did not reach the paper's disclosures.
What would settle it is the paper's own declaration section, usually printed at the end of the article and in the journal's supplementary files. That is the primary source, and it is the only one that counts for a question about what authors declared.
My call: I cannot answer this from the evidence retrieved, and I will not guess at a funding or conflict statement. Confidence: not clear.
Sources used 4
-
Favourite papers in infectious diseases 2004
A commentary summarizing the Lancet Infectious Diseases board’s top five favourite papers of 2004 in infectious diseases and highlighting the recurring themes they illustrate, such as pandemics, emerging infections, and the role of molecular biology.
DOI: 10.1016/S1473-3099(04)01200-9 -
An opportunity for further control of hepatitis B in China?
CDC commentary on a Lancet Infectious Diseases study showing substantial hepatitis B exposure and chronic infection among rural Chinese men, with regional vaccination disparities and implications for targeted vaccination and treatment programs using the NFPHEP data.
DOI: 10.1016/S1473-3099(15)00245-5 -
Tests for prediction of active tuberculosis
This Lancet Infectious Diseases commentary reviews the predictive value of interferon-γ release assays (IGRAs) for progression from latent tuberculosis infection to active TB, compares them with the tuberculin skin test (TST), discusses methodological limitations, and emphasizes…
DOI: 10.1016/s1473-3099(11)70215-8 -
Crohn's disease, mycobacteria, and NOD2
This study presents a case report of a 21-year-old man with Crohn's disease who showed evidence of Mycobacterium avium paratuberculosis infection, suggesting a potential link between mycobacterial infection and Crohn's disease pathogenesis.
DOI: 10.1016/s1473-3099(04)00935-1